CRT-D 在马凡综合征伴心力衰竭、室性心动过速和心室颤动患者中的应用。
Application of CRT-D in a Marfan syndrome patient with chronic heart failure accompanied by ventricular tachycardia and ventricular fibrillation.
机构信息
Department of Cardiology, Hangzhou First People's Hospital, Hangzhou 310006, China.
出版信息
J Zhejiang Univ Sci B. 2013 Aug;14(8):759-62. doi: 10.1631/jzus.BQICC710.
Abstract
Marfan syndrome is a systemic connective tissue disease that could affect the cardiovascular system and eventually lead to heart enlargement and heart failure with high mortality, mainly due to progressive heart failure and/or sudden cardiac death caused by malignant arrhythmia. Here we report that a patient received a cardiac resynchronization therapy-defibrillator (CRT-D) with a pre-monitor function for heart failure and experienced obvious improvements in his cardiac function. Postoperative follow-up showed that the patient had reduced morbidity and hospitalization for heart failure, and also experienced improved quality of life.
摘要
马凡综合征是一种系统性结缔组织疾病，可累及心血管系统，最终导致心脏扩大和心力衰竭，病死率高，主要是由于进行性心力衰竭和/或恶性心律失常导致的心脏性猝死。本研究报道了 1 例马凡综合征患者因心力衰竭行心脏再同步治疗除颤器（CRT-D）植入，并带有心力衰竭预监测功能，患者心功能明显改善。术后随访发现患者心力衰竭的发病率和住院率降低，生活质量得到提高。
相似文献
1
Application of CRT-D in a Marfan syndrome patient with chronic heart failure accompanied by ventricular tachycardia and ventricular fibrillation.CRT-D 在马凡综合征伴心力衰竭、室性心动过速和心室颤动患者中的应用。
J Zhejiang Univ Sci B. 2013 Aug;14(8):759-62. doi: 10.1631/jzus.BQICC710.
2
Heart failure as a substrate and trigger for ventricular tachycardia.心力衰竭作为室性心动过速的基质和触发因素。
J Interv Card Electrophysiol. 2019 Dec;56(3):229-247. doi: 10.1007/s10840-019-00623-x. Epub 2019 Oct 9.
3
Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRT.心脏再同步治疗对右心室大小的反应与 MADIT-CRT 中室性心律失常的风险。
Heart Rhythm. 2013 Oct;10(10):1471-7. doi: 10.1016/j.hrthm.2013.07.029. Epub 2013 Jul 19.
4
Cardiac Resynchronization Therapy Reduces Ventricular Arrhythmias in Primary but Not Secondary Prophylactic Implantable Cardioverter Defibrillator Patients: Insight From the Resynchronization in Ambulatory Heart Failure Trial.心脏再同步治疗可减少原发性而非继发性预防性植入式心律转复除颤器患者的室性心律失常：来自门诊心力衰竭试验中再同步治疗的见解。
Circ Arrhythm Electrophysiol. 2017 Mar;10(3). doi: 10.1161/CIRCEP.116.004875.
5
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).多中心自动除颤器植入试验-心脏再同步治疗（MADIT-CRT）中 QRS 形态对心脏再同步治疗效果的影响。
Circulation. 2011 Mar 15;123(10):1061-72. doi: 10.1161/CIRCULATIONAHA.110.960898. Epub 2011 Feb 28.
6
Cardiac device therapy in patients with left ventricular dysfunction and heart failure: 'real-world' data on long-term outcomes (mortality, hospitalizations, days alive and out of hospital).左心室功能障碍和心力衰竭患者的心脏装置治疗：长期结局（死亡率、住院率、生存天数和院外天数）的“真实世界”数据。
Eur J Heart Fail. 2016 Jun;18(6):693-702. doi: 10.1002/ejhf.509. Epub 2016 Apr 6.
7
Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.采用一套新型检测算法减少心脏再同步治疗除颤器治疗的心力衰竭患者不适当的抗心动过速起搏治疗和电击：前瞻性数据库的历史对照研究
Europace. 2016 Sep;18(9):1391-8. doi: 10.1093/europace/euv420. Epub 2016 Jan 29.
8
Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".心力衰竭中的抗心律失常药物或植入式心脏复律除颤器：“脆弱的心脏”
Am J Cardiol. 1999 Mar 11;83(5B):83D-87D. doi: 10.1016/s0002-9149(98)01039-x.
9
Dyssynchrony and the risk of ventricular arrhythmias.不同步与室性心律失常风险。
JACC Cardiovasc Imaging. 2013 Apr;6(4):432-44. doi: 10.1016/j.jcmg.2012.12.008.
10
Risk of Ventricular Tachyarrhythmic Events in Patients Who Improved Beyond Guidelines for a Defibrillator in MADIT-CRT.在 MADIT-CRT 中，那些改善程度超过除颤器指南建议的患者发生室性心律失常事件的风险。
JACC Clin Electrophysiol. 2019 Oct;5(10):1172-1181. doi: 10.1016/j.jacep.2019.08.009. Epub 2019 Oct 2.
引用本文的文献
1
Fatal Ventricular Fibrillation Storm in a Young Patient with Marfan Syndrome.一名患有马凡综合征的年轻患者发生致命性室颤风暴
J Emerg Trauma Shock. 2023 Jul-Sep;16(3):140-141. doi: 10.4103/jets.jets_53_23. Epub 2023 Aug 10.
2
Cardiovascular Management of Adults with Marfan Syndrome.马凡综合征成人患者的心血管管理
Eur Cardiol. 2016 Dec;11(2):102-110. doi: 10.15420/ecr/2016:19:2.
本文引用的文献
1
Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT.缺血性和非缺血性心肌病患者接受心脏再同步化治疗预防的反应：MADIT-CRT 研究。
Eur Heart J. 2011 Jul;32(13):1622-30. doi: 10.1093/eurheartj/ehq407. Epub 2010 Nov 12.
2
Results of the Predictors of Response to CRT (PROSPECT) trial.心脏再同步化治疗反应预测因子（PROSPECT）试验的结果。
Circulation. 2008 May 20;117(20):2608-16. doi: 10.1161/CIRCULATIONAHA.107.743120. Epub 2008 May 5.
3
Acute evaluation of programmer-guided AV/PV and VV delay optimization comparing an IEGM method and echocardiogram for cardiac resynchronization therapy in heart failure patients and dual-chamber ICD implants.在心力衰竭患者和双腔植入式心律转复除颤器植入患者中，比较一种心内心电图方法和超声心动图对心脏再同步治疗进行程控引导的房室/室间延迟优化的急性评估。
J Cardiovasc Electrophysiol. 2007 Feb;18(2):185-91. doi: 10.1111/j.1540-8167.2006.00671.x.
4
Left intraventricular myocardial deformation dyssynchrony identifies responders to cardiac resynchronization therapy in patients with heart failure.左心室内心肌变形不同步可识别心力衰竭患者中对心脏再同步治疗有反应者。
Eur Heart J. 2006 May;27(9):1070-8. doi: 10.1093/eurheartj/ehi814. Epub 2006 Mar 30.
5
Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy.基于常规黑白超声心动图图像的新型斑点追踪径向应变，用于量化不同步性并预测心脏再同步治疗的反应。
Circulation. 2006 Feb 21;113(7):960-8. doi: 10.1161/CIRCULATIONAHA.105.571455. Epub 2006 Feb 13.
6
Utility of echocardiographic tissue synchronization imaging to redirect left ventricular lead placement for improved cardiac resynchronization therapy.超声心动图组织同步成像在重新定位左心室电极导线以改善心脏再同步治疗中的应用价值。
Pacing Clin Electrophysiol. 2005 May;28(5):461-5. doi: 10.1111/j.1540-8159.2005.40056.x.
7
Defibrillation threshold testing: is it really necessary at the time of implantable cardioverter-defibrillator insertion?除颤阈值测试：在植入式心律转复除颤器植入时真的有必要吗？
Heart Rhythm. 2005 May;2(5):456-61. doi: 10.1016/j.hrthm.2005.01.015.
8
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.晚期慢性心力衰竭患者接受或不接受植入式除颤器的心脏再同步治疗。
N Engl J Med. 2004 May 20;350(21):2140-50. doi: 10.1056/NEJMoa032423.
9
Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography.心脏再同步治疗后左心室功能的改善可通过组织多普勒成像超声心动图预测。
Circulation. 2004 Mar 2;109(8):978-83. doi: 10.1161/01.CIR.0000116765.43251.D7. Epub 2004 Feb 9.
Zotero 插件